Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-09T06:08:51.706Z Has data issue: false hasContentIssue false
  • English
  • Français

The metabolic response to cancer

Published online by Cambridge University Press:  28 February 2007

Johan Gelin  and
Kent Lundholm
Johan Gelin
Affiliation:
Department of Surgery, Institution I and II, University of Göteborg, Sahlgrenska Hospital, Göteborg, Sweden
Kent Lundholm
Affiliation:
Department of Surgery, Institution I and II, University of Göteborg, Sahlgrenska Hospital, Göteborg, Sweden
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposium on ‘New strategies for manipulating the metabolic reponse to severe illness’
Information
Proceedings of the Nutrition Society , Volume 51 , Issue 2 , August 1992 , pp. 279 - 284
Copyright
Copyright © The Nutrition Society 1992

References

Balkwill, R. B., Naylor, S. N. & Malek, S. (1990). Tumor necrosis factor as ar; anticancer agent. European Journal of Cancer 26, 641–644.CrossRefGoogle Scholar
Busbridge, J., Dascombe, M. J., Hoopkins, S. & Rothwell, N. J. (1989). Acute central effects of interleukin-6 on body temperature, thermogenesis and food intake in the rat. Proceedings of the Nutrition Society 38, 48A.Google Scholar
Carter, D. B., Deibel, M. R. Jr, Dunn, C. J., Tomich, C. S. C., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., Harri, P. K. W., Yem, A. W., Waszak, G. A., Chosay, J. G., Sieu, L. C., Hardee, M. M., Zurcher-Neely, H. A., Reardon, I. M., Heinrikson, R. L., Truesdell, S. E., Shelly, J. A., Eessalu, T. E., Taylor, B. M. & Tracey, D. E. (1990). Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344, 633–638.CrossRefGoogle ScholarPubMed
Drott, C., Person, H. & Lundholm, K. (1989). Cardiovascular and metabolic response to adrenaline infusion in undernourished patients with and without cancer. Clinical Physiology 9, 427–439.CrossRefGoogle ScholarPubMed
Drott, C., Svaninger, G. & Lundholm, K. (1988). Increased urinary excretion of cortisol and catecholamines in malnourished cancer patients. Annals of Surgery 208, 645–650.CrossRefGoogle ScholarPubMed
Drott, C., Waldenstrom, A. & Lundholm, K. (1987). Cardiac sensitivity and responsiveness to P-adrenergic stimulation in experimental cancer and undernutrition. Journal of Molecular and Cellular Cardiology 19, 675–683.CrossRefGoogle Scholar
Gelin, J., Andersson, C. & Lundholm, K. (1991 a). Effects of indomethacin, cytokines and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Research 51, 880–885.Google ScholarPubMed
Gelin, J., Moldawer, I., Iresjö, B. M. & Lundholm, K. (1992). The role of the adrenals in the acute-phase response to interleukin 1 and tumor necrosis factor alpha. Journal ofsurgical Research. (In the Press).Google Scholar
Gelin, J., Moldawer, L. L., Lönnroth, C., Sherry, B., Chizzonite, R. & Lundholm, K. G. (1991 b). The role of endogenous tumour necrosis factor a and Interleukin-1 for experimental tumour growth and the development of cancer cachexia. Cancer Research 51, 440–445.Google ScholarPubMed
Hyltander, A., Drott, C., Körner, U., Sandströ, R. & Lundholm, K. (1991). Elevated energy expenditure in cancer patients with solid tumours. European Journal of Cancer 27, 9–15.CrossRefGoogle ScholarPubMed
Jablons, D. M., Mul´, J. J., McIntosh, J. K., Sehgel, P. B., May, L. T., Huang, C. M., Roenberg, S. A. & Lotze, M. T. (1989). Interleukin-6/Interferon-β2 as a circulating hormone. Journal of Immunology 142, 1542–1547.CrossRefGoogle ScholarPubMed
Lönnroth, C., Moldawer, L., Gelin, J., Kindblom, L. G., Sherry, B. & Lundholm, K. (1990). Tumor necrosis factor alpha and interleukin 1 alpha production in cachectic, tumor-bearing mice. International Journal of Cancer 46, 889–896.CrossRefGoogle ScholarPubMed
Naylor, M. S., Stamp, G. W. H. & Balkwill, F. R. (1990). Investigation of cytokine gene expression in human colorectal cancer. Cancer Research 50, 4436–4440.Google ScholarPubMed
Sherry, B. A., Gelin, J., Fong, Y., Marano, M., Wei, H., Cerami, A., Lowry, S. F. & Lundholm, K. G. (1989). Anticachectin/tumor necrosis factor-a antibodies attenuate development of cachexia in tumor models. FASEB Journal 3, 1956–1962.CrossRefGoogle Scholar
Warnold, I., Lundholm, K. & Scherst´n, T. (1978). Energy balance and body composition in cancer patients. Cancer Research 38, 1801–1807.Google ScholarPubMed
Westin, T. (1990). Ornithine decarboxylase activity in malignant tumors. An experimental and clinical study with reference to cell proliferation and nutrition. Thesis, University of Goteborg.Google Scholar